Treatment Registry
TR-0466 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by Harbor · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$119

Medication · Tirzepatide Program, as low as$119

Added from the figures recorded below.

Price

TermPer monthCharged today
Tirzepatide Program, as low as

Accelerated Weekly Injectable COMPOUNDED GLP-1/GIP Tirzepatide Program As low as $119/mo 1 simple weekly injection Curbs appetite, reduces cravings, and accelerates metabolism

source

Per month$119Charged today$119
Visit Harbor

We earn nothing from this link. Harbor has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PrescriberBoth
Cancellation“Cancel Anytime ... We believe you'll reach your goal with us. If you don't, we'll refund you every penny. It's that simple. ... 12-Month Money Back Guarantee”

Not yet checked: pharmacy, states, membership and consult fee.

Recorded from visitharbor.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 3, 2026Harbor serves two different prices for this program from the same address, and which one a visitor sees appears to be decided per visit. Fourteen identical requests on 3 September 2026 returned “As low as $99/mo” nine times and “As low as $89/mo” five times, with the tirzepatide program at $149 and $119 alongside them and the page's own “Start for $99” / “Start for $89” sign-up figure moving in step each time. Every figure on a given page load agrees with the others, so this is one price presented two ways rather than a page half-loading. Both are Harbor's own published prices. The figure recorded here is the lower of the two; a reader opening the page may be shown the higher one.

1 further note concerns other Harbor programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0466
Readings
1

Related records

What else Harbor sells

All Harbor programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Harbor compounded tirzepatide (TR-0466). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0466

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.